Adage Capital Partners’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-475,000
Closed -$24.2M 1039
2025
Q4
$24.2M Buy
+475,000
New +$24.3M 0.04% 426
2024
Q4
Sell
-794,125
Closed -$94.6M 938
2024
Q3
$94.6M Buy
794,125
+34,750
+5% +$4.63M 0.17% 113
2024
Q2
$108M Sell
759,375
-58,451
-7% -$7.75M 0.2% 100
2024
Q1
$105M Buy
817,826
+3,434
+0.4% +$409K 0.2% 105
2023
Q4
$84.2M Sell
814,392
-544,212
-40% -$53.8M 0.17% 135
2023
Q3
$124M Buy
1,358,604
+205,368
+18% +$18.1M 0.28% 76
2023
Q2
$93.3M Buy
1,153,236
+637,618
+124% +$52.1M 0.2% 124
2023
Q1
$41M Sell
515,618
-192,754
-27% -$13.7M 0.09% 256
2022
Q4
$47.9M Sell
708,372
-68,168
-9% -$4M 0.11% 217
2022
Q3
$38.7M Sell
776,540
-221,070
-22% -$11.8M 0.1% 225
2022
Q2
$55.6M Sell
997,610
-120,390
-11% -$6.68M 0.13% 169
2022
Q1
$62.1M Buy
1,118,000
+68,000
+6% +$3.49M 0.12% 177
2021
Q4
$58.8M Buy
+1,050,000
New +$56.9M 0.11% 193
2020
Q4
Sell
-200,000
Closed -$6.94M 866
2020
Q3
$6.94M Sell
200,000
-200,000
-50% -$6.67M 0.02% 579
2020
Q2
$13.1M Sell
400,000
-400,000
-50% -$12.8M 0.03% 485
2020
Q1
$24.1M Sell
800,000
-800,000
-50% -$23.8M 0.07% 285
2019
Q4
$46.3M Sell
1,600,000
-600,000
-27% -$16.6M 0.11% 221
2019
Q3
$56.9M Sell
2,200,000
-1,000,000
-31% -$25.3M 0.14% 179
2019
Q2
$81.7M Buy
3,200,000
+1,820,000
+132% +$45M 0.2% 128
2019
Q1
$36.1M Sell
1,380,000
-350,000
-20% -$8.6M 0.09% 260
2018
Q4
$39.9M Buy
1,730,000
+730,000
+73% +$16.2M 0.11% 210
2018
Q3
$23.6M Buy
1,000,000
+400,000
+67% +$9.76M 0.05% 365
2018
Q2
$13.8M Sell
600,000
-400,000
-40% -$9.51M 0.03% 495
2018
Q1
$24.6M Sell
1,000,000
-400,000
-29% -$10.5M 0.06% 351
2017
Q4
$37.6M Sell
1,400,000
-200,000
-13% -$5.09M 0.09% 275
2017
Q3
$38.5M Buy
1,600,000
+200,000
+14% +$4.52M 0.09% 264
2017
Q2
$30M Buy
1,400,000
+1,200,000
+600% +$24.2M 0.07% 329
2017
Q1
$3.43M Buy
+200,000
New +$3.48M 0.01% 640

Other funds holding NVO